[go: up one dir, main page]

SG10201900614PA - Maternal DPA for benefit of mother and/or child’s mental health - Google Patents

Maternal DPA for benefit of mother and/or child’s mental health

Info

Publication number
SG10201900614PA
SG10201900614PA SG10201900614PA SG10201900614PA SG10201900614PA SG 10201900614P A SG10201900614P A SG 10201900614PA SG 10201900614P A SG10201900614P A SG 10201900614PA SG 10201900614P A SG10201900614P A SG 10201900614PA SG 10201900614P A SG10201900614P A SG 10201900614PA
Authority
SG
Singapore
Prior art keywords
dpa
maternal
mother
child
benefit
Prior art date
Application number
SG10201900614PA
Inventor
Karnani Neerja
Kum Peng Wong Gerard
David Gluckman Peter
Joseph Meaney Michael
Original Assignee
Agency For Science Technology And Research Astarstar
Nat Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency For Science Technology And Research Astarstar, Nat Univ Singapore filed Critical Agency For Science Technology And Research Astarstar
Priority to SG10201900614PA priority Critical patent/SG10201900614PA/en
Priority to CN202080008355.9A priority patent/CN113301892A/en
Priority to SG11202107991UA priority patent/SG11202107991UA/en
Priority to PCT/SG2020/050035 priority patent/WO2020153907A1/en
Priority to BR112021014237A priority patent/BR112021014237A2/en
Priority to JP2021541694A priority patent/JP2022522097A/en
Priority to EP20703847.2A priority patent/EP3914243A1/en
Priority to KR1020217026471A priority patent/KR20210137448A/en
Priority to US17/421,540 priority patent/US20220087964A1/en
Publication of SG10201900614PA publication Critical patent/SG10201900614PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG10201900614PA 2019-01-23 2019-01-23 Maternal DPA for benefit of mother and/or child’s mental health SG10201900614PA (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SG10201900614PA SG10201900614PA (en) 2019-01-23 2019-01-23 Maternal DPA for benefit of mother and/or child’s mental health
CN202080008355.9A CN113301892A (en) 2019-01-23 2020-01-23 Maternal DPA beneficial to maternal and/or mental health of children
SG11202107991UA SG11202107991UA (en) 2019-01-23 2020-01-23 Maternal dpa for benefit of mother and/or child's mental health
PCT/SG2020/050035 WO2020153907A1 (en) 2019-01-23 2020-01-23 Maternal dpa for benefit of mother and/or child's mental health
BR112021014237A BR112021014237A2 (en) 2019-01-23 2020-01-23 Maternal DPA to benefit the mental health of the mother and/or child
JP2021541694A JP2022522097A (en) 2019-01-23 2020-01-23 Mother's DPA for the mental health of the mother and / or the child
EP20703847.2A EP3914243A1 (en) 2019-01-23 2020-01-23 Maternal dpa for benefit of mother and/or child's mental health
KR1020217026471A KR20210137448A (en) 2019-01-23 2020-01-23 Maternal Docosapentaenoic Acid Beneficial to Maternal and/or Child's Mental Health
US17/421,540 US20220087964A1 (en) 2019-01-23 2020-01-23 Maternal dpa for benefit of mother and/or child's mental health

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201900614PA SG10201900614PA (en) 2019-01-23 2019-01-23 Maternal DPA for benefit of mother and/or child’s mental health

Publications (1)

Publication Number Publication Date
SG10201900614PA true SG10201900614PA (en) 2020-08-28

Family

ID=71737446

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201900614PA SG10201900614PA (en) 2019-01-23 2019-01-23 Maternal DPA for benefit of mother and/or child’s mental health
SG11202107991UA SG11202107991UA (en) 2019-01-23 2020-01-23 Maternal dpa for benefit of mother and/or child's mental health

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11202107991UA SG11202107991UA (en) 2019-01-23 2020-01-23 Maternal dpa for benefit of mother and/or child's mental health

Country Status (8)

Country Link
US (1) US20220087964A1 (en)
EP (1) EP3914243A1 (en)
JP (1) JP2022522097A (en)
KR (1) KR20210137448A (en)
CN (1) CN113301892A (en)
BR (1) BR112021014237A2 (en)
SG (2) SG10201900614PA (en)
WO (1) WO2020153907A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2362515C (en) * 1999-03-04 2008-07-15 Suntory Limited Utilization of material containing docosapentaenoic acid
KR100758664B1 (en) * 2006-08-16 2007-09-13 (주)케비젠 Method for preparing unsaturated fatty acid-containing microcapsules, microcapsules prepared by the method and products containing the same
EP2861227A4 (en) * 2012-06-17 2016-01-27 Matinas Biopharma Inc OMEGA-3 PENTANOIC ACID COMPOSITIONS AND METHODS OF USE

Also Published As

Publication number Publication date
SG11202107991UA (en) 2021-08-30
CN113301892A (en) 2021-08-24
EP3914243A1 (en) 2021-12-01
WO2020153907A1 (en) 2020-07-30
US20220087964A1 (en) 2022-03-24
BR112021014237A2 (en) 2021-11-30
JP2022522097A (en) 2022-04-14
KR20210137448A (en) 2021-11-17

Similar Documents

Publication Publication Date Title
IL254791A0 (en) Artery medical apparatus and methods of use thereof
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3727406C0 (en) PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH
IL271117B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
PL3727410T3 (en) PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH
IL253999A0 (en) Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases
IL272097A (en) Compounds for the prevention and treatment of medical disorders and uses thereof
ZA201801300B (en) Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections
ZA201800037B (en) Diagnosis and treatment of infectious disease
PL2810624T3 (en) Pillow for the treatment and/or prevention of cranial deformities in babies and infants
GB201710822D0 (en) Methods and medical uses relating to the treatment of hypoglycaemia
EP3427731A4 (en) IMPROVEMENT AGENT FOR IMPROVING PHYSICAL AND / OR MENTAL SYMPTOM SPECIFIC TO WOMEN
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
EP3518668A4 (en) Genetic susceptibility diagnosis and treatment of mental disorders
SG10201900614PA (en) Maternal DPA for benefit of mother and/or child’s mental health
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
ZA201903572B (en) Compositions and methods for the treatment of oral infectious diseases
SG11201609389QA (en) Diagnostic test and treatment/prevention of alzheimer's disease
ZA201806864B (en) Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in parkinson's disease patients
PT3595660T (en) Compounds for use in the prevention and/or treatment of non-alcoholic fat liver disease and non-alcoholic steatohepatitis
GB201904717D0 (en) Treatment and diagnosis of mental disorders
HK40016569A (en) Use of nad precursors for improving maternal health and/or offspring health
Xiaoli et al. Influence of body position intervention on intracranial pressure of traumatic brain injury patients.
GB201716026D0 (en) Mental health patients
GB201721304D0 (en) Probiotics for cognitive and mental health